MetLife Investment Management LLC Grows Position in Exponent, Inc. (NASDAQ:EXPO)

MetLife Investment Management LLC raised its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 8.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 58,331 shares of the business services provider's stock after purchasing an additional 4,461 shares during the period. MetLife Investment Management LLC owned approximately 0.11% of Exponent worth $5,197,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in EXPO. Raymond James Financial Inc. purchased a new position in Exponent in the 4th quarter worth $55,131,000. Norges Bank bought a new position in shares of Exponent during the fourth quarter valued at about $52,381,000. Resona Asset Management Co. Ltd. purchased a new position in shares of Exponent in the fourth quarter worth about $38,538,000. JPMorgan Chase & Co. lifted its stake in shares of Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock valued at $72,701,000 after acquiring an additional 245,086 shares during the last quarter. Finally, Barclays PLC boosted its holdings in Exponent by 88.5% during the 4th quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock valued at $16,209,000 after acquiring an additional 85,395 shares during the period. Institutional investors own 92.37% of the company's stock.

Exponent Stock Performance

EXPO traded up $0.30 on Tuesday, hitting $78.50. 67,302 shares of the company were exchanged, compared to its average volume of 240,712. Exponent, Inc. has a 12 month low of $73.83 and a 12 month high of $115.75. The firm has a fifty day simple moving average of $81.17 and a two-hundred day simple moving average of $90.50. The stock has a market capitalization of $3.98 billion, a PE ratio of 37.03 and a beta of 0.84.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period in the previous year, the business earned $0.41 EPS. On average, equities analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current year.

Insider Buying and Selling at Exponent

In other news, VP Richard Reiss sold 1,736 shares of the stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the completion of the sale, the vice president now directly owns 1,800 shares in the company, valued at approximately $154,674. This represents a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.10% of the company's stock.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.